Technology · Information Technology Services · NASDAQ
ChronoScale (CHRN) is a Technology company in the Information Technology Services industry. It has a market capitalization of $1.57B and a free-cash-flow yield of 0.8%. Over the most recent reported fiscal year, revenue declined 15.1%. Nama's AI scorecard rates it Sell, 2.5 out of 10. On 12-month momentum it ranks in the leading band of its market.
AI scorecard
Sell · 2.5/10
Clearly negative, short of the bottom band. As of Nov 7, 2026.
Momentum
Leading · +307.6% over 12 months ex. last
Top 20% of its market on the past year's steady rise.
Shariah screen
Can't Tell
A figure the screen needs is missing, so it can't tell.
Off its high
-83.1%
How far the last close sits under the highest price of the past five years.
Market cap
$1.57B
Trailing P/E
—
Price / book
10.4
Price / sales
16.3
FCF yield
0.8%
Dividend yield
—
Gross margin
-14.6%
Operating margin
-60.0%
Net margin
-84.6%
Revenue growth (YoY)
-15.1%
Revenue growth (3-yr annual)
—
EPS growth (YoY)
—
FCF/share growth (YoY)
—
Beta
1.0
Exchange
NASDAQ
Sector
Technology
Industry
Information Technology Services
CHRN earnings
Beat the EPS estimate in 1 of 1 recent quarters.
Quarter
Reported
EPS
Estimate
Surprise
Revenue
Q1 2027
Oct 14, 2026
-$0.08
-$0.09
+11.1%
$41.48M
CHRN analyst price target
Median target $28.50 from 2 analysts, ranging $25.00 – $32.00.
Nama's AI scorecard currently rates ChronoScale Sell (2.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is the CHRN price target?
The median analyst price target from 2 analysts is $28.50, with a range of $25.00 – $32.00.
Is CHRN Shariah compliant?
Nama's AAOIFI-style screen reads ChronoScale as Can't Tell. A figure the screen needs is missing, so it can't tell.